FierceBiotechOriginal article
{"a":[{"_":"FDA clears Aptitude’s latest Metrix molecular dx to test for COVID","$":{"href":"/medtech/fda-clears-aptitudes-latest-matrix-molecular-dx-test-covid","hreflang":"en"}}]}
RegulatoryapprovedMetrix COVID diagnosticPositive
AI Analysis
Summary
Aptitude received FDA 510(k) clearance for its next-generation Metrix COVID diagnostic, which offers three-times greater sensitivity and 30% faster results compared to the original emergency use authorized test.
Outcome Details
FDA granted 510(k) clearance for next-generation Metrix COVID diagnostic with three-times greater sensitivity and 30% faster results than original EUA test
Importance:6/10
Sentiment:
0.75
FDA clearance510(k)diagnosticCOVID-19molecular test
Read the original article
Published by FierceBiotech on September 18, 2026 8:59 AM